Pharmalex Us Corporation
UEI: XFLXMFKCJQN1
• CAGE: 884Z0
Overview
Awardee Type
Parent
(1 child)
Company Description
Pharma consulting of specialized services for the pharmaceutical, biotech and medical device industries, compliance is our top priority.
Name
Pharmalex Us Corporation
Website
Headquarters
Conshohocken, PA
United States
United States
Most Recent Award
April 15, 2022
Calculating
Federal contract recipient
PHARMALEX US CORPORATION
(UEI XFLXMFKCJQN1, CAGE 884Z0)
is headquartered in Conshohocken PA.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in April 2018 and
federally registered in
January 2019.
Federal Award Analysis
Pharmalex Us Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PHARMALEX US CORPORATION
UEI
XFLXMFKCJQN1
CAGE Code
884Z0
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 1, 2018
Initial Registration
Jan. 4, 2019
Last Registration
March 31, 2026
Registration Activation
March 31, 2026
Registration Expiration
March 27, 2027
Fiscal Year End
September 30
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
Yes